A citation-based method for searching scientific literature

Won Chul Chang, Han Kyeom Kim, Bong Kyung Shin. Oncol Rep 2020
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel KIF5B-ALK Fusion Oncokinase.
Naoki Shimizu, Yusaku Akashi, Tomomi Fujii, Hiroyuki Shiono, Katsunari Yane, Tadashi Kitahara, Yoshio Ohta, Kennichi Kakudo, Tomoko Wakasa. Anticancer Res 2019
2
50


CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer.
Meiling Zhang, Qian Wang, Yan Ding, Guoqun Wang, Yunqian Chu, Xiang He, Xue Wu, Yang W Shao, Kaihua Lu. J Thorac Oncol 2018
18
33


Large Cell Neuroendocrine Carcinoma Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement with Response to Alectinib.
Nobuyoshi Hayashi, Akihisa Fujita, Toyohiro Saikai, Hirotugu Takabatake, Mie Sotoshiro, Kyuutarou Sekine, Akihiko Kawana. Intern Med 2018
10
33

Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas.
Melissa Frizziero, Francesca Spada, Angela Lamarca, Zoe Kordatou, Jorge Barriuso, Christina Nuttall, Mairéad G McNamara, Richard A Hubner, Wasat Mansoor, Prakash Manoharan,[...]. Neuroendocrinology 2019
9
33

ALK-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature.
Qiang Zheng, Mingjia Zheng, Yan Jin, Xuxia Shen, Ling Shan, Lei Shen, Yihua Sun, Haiquan Chen, Yuan Li. Onco Targets Ther 2018
12
33

A case of large-cell neuroendocrine carcinoma harboring an EML4-ALK rearrangement with resistance to the ALK inhibitor crizotinib.
Naoki Omachi, Shigeki Shimizu, Tomoya Kawaguchi, Kenji Tezuka, Masaki Kanazu, Akihiro Tamiya, Kazuhiro Asami, Kyoichi Okishio, Masanori Kitaichi, Shinji Atagi. J Thorac Oncol 2014
27
33


Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.
Chen Lin, Xun Shi, Shao Yang, Jun Zhao, Qiong He, Ying Jin, Xinmin Yu. Lung Cancer 2019
36
33

Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH.
Eunhee S Yi, Jennifer M Boland, Joseph J Maleszewski, Anja C Roden, Andre M Oliveira, Marie-Christine Aubry, Michele R Erickson-Johnson, Bolette L Caron, Yan Li, Hui Tang,[...]. J Thorac Oncol 2011
220
33

Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
Stefania Morganti, Paolo Tarantino, Emanuela Ferraro, Paolo D'Amico, Giulia Viale, Dario Trapani, Bruno Achutti Duso, Giuseppe Curigliano. Crit Rev Oncol Hematol 2019
32
33

Detection of ALK-positive non-small-cell lung cancers on cytological specimens: high accuracy of immunocytochemistry with the 5A4 clone.
Spasenija Savic, Beata Bode, Joachim Diebold, Ivo Tosoni, Audrey Barascud, Betty Baschiera, Bruno Grilli, Michelle Herzog, Ellen Obermann, Lukas Bubendorf. J Thorac Oncol 2013
73
33

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
33

ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH.
Eugen C Minca, Bryce P Portier, Zhen Wang, Christopher Lanigan, Carol F Farver, Yan Feng, Patrick C Ma, Valeria A Arrossi, Nathan A Pennell, Raymond R Tubbs. J Mol Diagn 2013
94
33

Simultaneous VENTANA IHC and RT-PCR testing of ALK status in Chinese non-small cell lung cancer patients and response to crizotinib.
Chun-Wei Xu, Wen-Xian Wang, Yan-Ping Chen, Yu Chen, Wei Liu, Li-Hua Zhong, Fang-Fang Chen, Wu Zhuang, Zheng-Bo Song, Xiao-Hui Chen,[...]. J Transl Med 2018
9
33

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Neal I Lindeman, Philip T Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire,[...]. J Mol Diagn 2013
336
33

ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.
Sanja Dacic, Liza C Villaruz, Shira Abberbock, Alyssa Mahaffey, Pimpin Incharoen, Marina N Nikiforova. Oncotarget 2016
41
33

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
Manabu Soda, Young Lim Choi, Munehiro Enomoto, Shuji Takada, Yoshihiro Yamashita, Shunpei Ishikawa, Shin-ichiro Fujiwara, Hideki Watanabe, Kentaro Kurashina, Hisashi Hatanaka,[...]. Nature 2007
33


Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer.
Yi-Long Wu, Shun Lu, You Lu, Jianying Zhou, Yuan-Kai Shi, Virote Sriuranpong, James C M Ho, Choo Khoon Ong, Chun-Ming Tsai, Chin-Hee Chung,[...]. J Thorac Oncol 2018
66
33

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
Alice T Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, Takashi Seto, Lucio Crinó, Myung-Ju Ahn, Tommaso De Pas, Benjamin Besse, Benjamin J Solomon, Fiona Blackhall,[...]. N Engl J Med 2013
33

Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non-Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases.
Anna Scattone, Annamaria Catino, Laura Schirosi, Lucia Caldarola, Stefania Tommasi, Rosanna Lacalamita, Elisabetta Sara Montagna, Domenico Galetta, Gabriella Serio, Francesco Alfredo Zito,[...]. Transl Oncol 2019
16
33

Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer.
David R Hout, Brock L Schweitzer, Kasey Lawrence, Stephan W Morris, Tracy Tucker, Rosetta Mazzola, Rachel Skelton, Frank McMahon, John Handshoe, Mary Lesperance,[...]. Cancers (Basel) 2017
13
33



Responses to Crizotinib therapy in five patients with non-small-cell lung cancer who tested FISH negative and Ventana immunohistochemistry positive for ALK fusions.
Jin-Lin Huang, Jing Zeng, Fang Wang, Qi-Tao Huang, Jia-Bin Lu, Xiao-Mei Li, Wei-Qiang Chen, Chong-Mei Zhu, Jie-Tian Jin, Su-Xia Lin. Per Med 2017
1
100

Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas.
Esther Conde, Susana Hernandez, Mario Prieto, Rebeca Martinez, Fernando Lopez-Rios. Expert Rev Mol Diagn 2016
30
33

Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Marina Pekar-Zlotin, Fred R Hirsch, Lior Soussan-Gutman, Maya Ilouze, Addie Dvir, Theresa Boyle, Murry Wynes, Vincent A Miller, Doron Lipson, Gary A Palmer,[...]. Oncologist 2015
113
33

Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Aaron C Tan, Gillianne G Y Lai, Gek San Tan, Shou Yu Poon, Brett Doble, Tse Hui Lim, Zaw Win Aung, Angela Takano, Wan Ling Tan, Mei-Kim Ang,[...]. Lung Cancer 2020
28
33


Renal Artery Stenosis Alters Gene Expression in Swine Scattered Tubular-Like Cells.
Arash Aghajani Nargesi, Xiang-Yang Zhu, Yuanhang Liu, Hui Tang, Kyra L Jordan, Lilach O Lerman, Alfonso Eirin. Int J Mol Sci 2019
4
33

ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?
Florian Cabillic, Paul Hofman, Marius Ilie, Nir Peled, Maximilian Hochmair, Manfred Dietel, Maximilian Von Laffert, John R Gosney, Fernando Lopez-Rios, Gilles Erb,[...]. ESMO Open 2018
14
33

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project.
Igor Letovanec, Stephen Finn, Panagiota Zygoura, Paul Smyth, Alex Soltermann, Lukas Bubendorf, Ernst-Jan Speel, Antonio Marchetti, Daisuke Nonaka, Kim Monkhorst,[...]. J Thorac Oncol 2018
45
33

Detection of Nonreciprocal/Reciprocal ALK Translocation as Poor Predictive Marker in Patients With First-Line Crizotinib-Treated ALK-Rearranged NSCLC.
Yongchang Zhang, Liang Zeng, Chunhua Zhou, Yizhi Li, Lin Wu, Chen Xia, Wenjuan Jiang, Yijuan Hu, Dehua Liao, Lili Xiao,[...]. J Thorac Oncol 2020
19
33

Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent.
Chris M J Conklin, Kenneth J Craddock, Cherry Have, Janessa Laskin, Christian Couture, Diana N Ionescu. J Thorac Oncol 2013
155
33

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
Alice T Shaw, Beow Y Yeap, Mari Mino-Kenudson, Subba R Digumarthy, Daniel B Costa, Rebecca S Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott,[...]. J Clin Oncol 2009
33

Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancer.
Liang Zeng, Yizhi Li, Lili Xiao, Yi Xiong, Li Liu, Wenjuan Jiang, Jianfu Heng, Jingjing Qu, Nong Yang, Yongchang Zhang. Onco Targets Ther 2018
9
33

Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine.
Simona Coco, Anna Truini, Irene Vanni, Maria Giovanna Dal Bello, Angela Alama, Erika Rijavec, Carlo Genova, Giulia Barletta, Claudio Sini, Giovanni Burrafato,[...]. Curr Drug Targets 2015
34
33

ALK testing in lung adenocarcinoma: technical aspects to improve FISH evaluation in daily practice.
Vittoria Martin, Barbara Bernasconi, Elisabetta Merlo, Piera Balzarini, William Vermi, Alice Riva, Anna Maria Chiaravalli, Milo Frattini, Nora Sahnane, Fabio Facchetti,[...]. J Thorac Oncol 2015
27
33

Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer.
Coureche Guillaume Kaderbhai, Romain Boidot, Françoise Beltjens, Sandy Chevrier, Laurent Arnould, Laure Favier, Aurélie Lagrange, Bruno Coudert, François Ghiringhelli. Oncotarget 2016
19
33

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
D Ross Camidge, Yung-Jue Bang, Eunice L Kwak, A John Iafrate, Marileila Varella-Garcia, Stephen B Fox, Gregory J Riely, Benjamin Solomon, Sai-Hong I Ou, Dong-Wan Kim,[...]. Lancet Oncol 2012
895
33

Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas.
Lynette M Sholl, Stanislawa Weremowicz, Stacy W Gray, Kwok-Kin Wong, Lucian R Chirieac, Neal I Lindeman, Jason L Hornick. J Thorac Oncol 2013
117
33

Association of Carbonic Anhydrase 9 Polymorphism and the Epithelial Growth Factor Receptor Mutations in Lung Adenocarcinoma Patients.
Ya-Yen Yu, Hui-Ling Chiou, Shih-Ming Tsao, Chen-Cheng Huang, Chih-Yun Lin, Chia-Yi Lee, Thomas Chang-Yao Tsao, Shun-Fa Yang, Yi-Wen Huang. Diagnostics (Basel) 2020
4
33

Determinants of survival in advanced non--small-cell lung cancer in the era of targeted therapies.
Joshua Bauml, Rosemarie Mick, Yu Zhang, Christopher D Watt, Anil Vachani, Charu Aggarwal, Tracey Evans, Corey Langer. Clin Lung Cancer 2013
29
33

Driver mutation profiles and clinicopathological correlation in pulmonary adenocarcinoma with a micropapillary component.
Jing Zhang, Jian Sun, Zhiwen Zhang, Anqi Wang, Xiaolong Liang, Junliang Lu, Zhiyong Liang. Hum Pathol 2019
2
50

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients.
Xu-Chao Zhang, Jun Wang, Guo-Guang Shao, Qun Wang, Xiaotao Qu, Bo Wang, Christopher Moy, Yue Fan, Zayed Albertyn, Xiayu Huang,[...]. Nat Commun 2019
79
33


Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma.
William Cruz-Muñoz, Maria L Jaramillo, Shan Man, Ping Xu, Myriam Banville, Catherine Collins, Andre Nantel, Giulio Francia, Sherif S Morgan, Lee D Cranmer,[...]. Cancer Res 2012
43
33

Untangling the ErbB signalling network.
Y Yarden, M X Sliwkowski. Nat Rev Mol Cell Biol 2001
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.